Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Total Debt (2016 - 2025)

Historic Total Debt for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $13.6 million.

  • Veracyte's Total Debt rose 8361.52% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 8361.52%. This contributed to the annual value of $17.0 million for FY2024, which is 53910.43% up from last year.
  • Latest data reveals that Veracyte reported Total Debt of $13.6 million as of Q3 2025, which was up 8361.52% from $13.4 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Total Debt registered a high of $17.0 million during Q4 2024, and its lowest value of $2.6 million during Q3 2023.
  • Over the past 5 years, Veracyte's median Total Debt value was $6.0 million (recorded in 2022), while the average stood at $6.8 million.
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 81564.17% in 2021, then plummeted by 6053.44% in 2022.
  • Quarter analysis of 5 years shows Veracyte's Total Debt stood at $2.7 million in 2021, then surged by 125.95% to $6.1 million in 2022, then plummeted by 56.16% to $2.7 million in 2023, then skyrocketed by 539.1% to $17.0 million in 2024, then fell by 20.08% to $13.6 million in 2025.
  • Its Total Debt was $13.6 million in Q3 2025, compared to $13.4 million in Q2 2025 and $14.4 million in Q1 2025.